I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Ritchie, Ellen
255
results:
Search for persons
X
Format
Online (255)
Mediatypes
Articles (Online) (124)
Bookchapter (Online) (4)
OpenAccess-fulltext (126)
Video (Online) (1)
Sorted by: Relevance
Sorted by: Year
?
1
MPN-556 Treatment Comparison of Hydroxyurea vs Ruxolitinib ..:
Grunwald, Michael R.
;
Ritchie, Ellen
;
Rumi, Elisa
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S403 , 2023
Link:
https://doi.org/10.1016/..
?
2
POSTER: MPN-548 Phase I/II Study of the Activin Receptor-li..:
Bose, Prithviraj
;
Mohan, Sanjay
;
Oh, Stephen
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S195 , 2023
Link:
https://doi.org/10.1016/..
?
3
MPN-541 Targeted Therapy of Uncontrolled Erythrocytosis in ..:
Pemmaraju, Naveen
;
Kremyanskaya, Marina
;
Kuykendall, Andrew
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S400-S401 , 2023
Link:
https://doi.org/10.1016/..
?
4
Safety and efficacy of zinpentraxin alfa as monotherapy or ..:
Verstovsek, Srdan
;
Foltz, Lynda
;
Gupta, Vikas
...
Haematologica. , 2023
Link:
https://doi.org/10.3324/..
?
5
P1046: TREATMENT COMPARISON OF HYDROXYUREA VS RUXOLITINIB I..:
Grunwald, Michael
;
Ritchie, Ellen
;
Rumi, Elisa
...
HemaSphere. 7 (2023) S3 - p. e94647fb , 2023
Link:
https://doi.org/10.1097/..
?
6
P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE ..:
Bose, Prithviraj
;
Mohan, Sanjay
;
Oh, Stephen
...
HemaSphere. 7 (2023) S3 - p. e41693dd , 2023
Link:
https://doi.org/10.1097/..
?
7
MPN-548 Phase I/II Study of the Activin Receptor-Like Kinas..:
Bose, Prithviraj
;
Mohan, Sanjay
;
Oh, Stephen
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S401-S402 , 2023
Link:
https://doi.org/10.1016/..
?
8
P517: SURVIVAL OUTCOMES WITH CPX-351 VS 7 + 3 BY BASELINE B..:
Ritchie, Ellen
;
L. Lin, Tara
;
F. Newell, Laura
...
HemaSphere. 7 (2023) S3 - p. e7753968 , 2023
Link:
https://doi.org/10.1097/..
?
9
POSTER: MPN-541 Targeted Therapy of Uncontrolled Erythrocyt..:
Pemmaraju, Naveen
;
Kremyanskaya, Marina
;
Kuykendall, Andrew
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S194 , 2023
Link:
https://doi.org/10.1016/..
?
10
POSTER: MPN-556 Treatment Comparison of Hydroxyurea vs Ruxo..:
Grunwald, Michael R.
;
Ritchie, Ellen
;
Rumi, Elisa
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S192 , 2023
Link:
https://doi.org/10.1016/..
?
11
MPN-186 Community Versus Academic Practice in Essential Thr..:
Lyons, Roger M.
;
Lessen, David
;
Fazal, Salman
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S329 , 2022
Link:
https://doi.org/10.1016/..
?
12
Poster: MPN-186 Community Versus Academic Practice in Essen..:
Lyons, Roger M.
;
Lessen, David
;
Fazal, Salman
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S157 , 2022
Link:
https://doi.org/10.1016/..
?
13
Patient-reported outcomes of patients with myelofibrosis or..:
Ritchie, Ellen
;
Al-Janadi, Anas
;
Kessler, Craig
...
Leukemia & Lymphoma. 63 (2022) 13 - p. 3138-3153 , 2022
Link:
https://doi.org/10.1080/..
?
14
MPN-469 Rusfertide (PTG-300) Treatment Interruption Reverse..:
Pemmaraju, Naveen
;
Kuykendall, Andrew
;
Kremyanskaya, Marina
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S338-S339 , 2022
Link:
https://doi.org/10.1016/..
?
15
Oral Abstract: MPN-469 Rusfertide (PTG-300) Treatment Inter..:
Pemmaraju, Naveen
;
Kuykendall, Andrew
;
Kremyanskaya, Marina
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S116 , 2022
Link:
https://doi.org/10.1016/..
1-15